Lastly, while in recent years clinical trials have been performed to examine the effects of oxytocin administration on anxiety and depressive disorders [53, 54], the role of individual differences in genetic makeup of the oxytocin system and the role of early life trauma in both the etiology of these disorders, and in the possible moderation of treatment effects are still unclear. This evidence concerns the gene OXT and depressive disorder.